A 28-year-old male with β-thalassemia major is found to have an unusual clinical presentation with residual β-globin production. Genetic analysis reveals a mutation in the 5′ untranslated region (5′ UTR) of the β-globin gene that affects mRNA stability. Which investigation would be most appropriate to directly assess the consequence of this mutation on mRNA processing and stability?

Explanation

## Investigation of Choice: Northern Blot Hybridization ### Why This Is Correct **Key Point:** A mutation in the 5′ UTR affects **mRNA stability and processing**, not transcription initiation or splicing. The most direct way to assess mRNA abundance and integrity is **Northern blot hybridization**, which: - Detects steady-state mRNA levels (reflects transcription + stability) - Identifies aberrant mRNA fragments (if the mutation causes premature degradation) - Quantifies relative β-globin mRNA in reticulocytes (the cell type with highest globin mRNA) **High-Yield:** 5′ UTR mutations commonly affect: - mRNA secondary structure (stem-loops that regulate stability) - Ribosome scanning and translation initiation - Binding sites for regulatory proteins and microRNAs - mRNA localization and export from nucleus ### Why Reticulocyte RNA? Reticulocytes are immature RBCs with active globin synthesis and abundant globin mRNA. They are the **gold standard tissue** for studying globin gene expression because: - Globin mRNA comprises ~90% of total mRNA (high signal-to-noise) - Minimal contamination from non-globin transcripts - Direct correlation between mRNA levels and protein output ### Diagnostic Workflow ```mermaid flowchart TD A[5' UTR mutation identified]:::outcome --> B{What is affected?}:::decision B -->|mRNA stability| C[Northern blot on reticulocyte RNA]:::action B -->|Splicing| D[RT-PCR or RNA-seq]:::action B -->|Transcription| E[ChIP or ATAC-seq]:::action C --> F[Reduced/fragmented mRNA = stability defect]:::outcome D --> G[Aberrant splice variants detected]:::outcome E --> H[Altered chromatin accessibility]:::outcome ``` ### Northern Blot vs. Alternative Methods | Investigation | Detects | Specificity for mRNA | Best For | |---|---|---|---| | **Northern blot** | mRNA size, abundance, integrity | Direct mRNA detection | mRNA stability, processing defects | | DNA sequencing | Genetic mutation | DNA only, not functional consequence | Identifying mutation, not effect | | ChIP | Protein-DNA interactions | Chromatin state, not mRNA | Transcription regulation | | Reporter assay | Protein expression from construct | Functional output, not mRNA directly | Trans-acting factors, promoter strength | | RT-PCR | mRNA presence/absence | Semi-quantitative | Quick screening, not comprehensive | **Clinical Pearl:** In β-thalassemia, 5′ UTR mutations (e.g., in the Kozak sequence or upstream AUG codons) reduce β-globin mRNA stability by ~50%, leading to mild anemia rather than severe thalassemia major. Northern blot shows reduced mRNA abundance compared to normal controls. ### Why This Mutation Affects mRNA, Not Transcription **Key Point:** The 5′ UTR is **post-transcriptional**. It does not affect: - RNA polymerase II recruitment (promoter is in the −100 to +1 region) - Transcription initiation rate - Splicing (which occurs in exons and introns, not UTRs) Instead, 5′ UTR mutations alter mRNA secondary structure, translation efficiency, and mRNA decay rates. [cite:Molecular Biology of the Gene, Watson et al. Chapter 18 — mRNA Stability and Localization]